NCT03457220View on ClinicalTrials.gov

An Observational Study to Evaluate AZD9291 Treatment in Patients With T790M Positive Non-small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

423

Participants

Timeline

Start Date

June 21, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Non Small Cell Lung Cancer
Trial Locations (7)

112

Research Site, Taipei

807

Research Site, Kaohsiung City

10002

Research Site, Taipei

40705

Research Site, Taichung

70403

Research Site, Tainan City

73657

Research Site, Tainan City

83301

Research Site, Kaohsiung City

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT03457220 - An Observational Study to Evaluate AZD9291 Treatment in Patients With T790M Positive Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter